Page 9 - Johnson Medtech News Today

For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular...

Inflation devices are likely to continue to improve as medical technology advances....

AtriCure (NYSE: ATRC) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.

Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market.

TECNIS PureSee IOL TECNIS PureSee Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson MedTech*, a global leader in eye health, announced today that its TECNIS PureSee purely refractive presbyopia-correcting lens is now available in EMEA. The TECNIS PureSee IOL features a proprietary, purely refractive design that delivers uninterrupted, high-quality, vision with high best-...

Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision LIMERICK, IRELAND, Feb. 15, 2024 (GLOBE...

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Johnson & Johnson MedTech announced that its Vision unit made the Tecnis PureSee lens available in the EMEA region.

Biosense Webster today announced its support for two collaborative studies using its Varipulse pulsed field ablation platform.

I Wish, founded by three Cork women more than 10 years ago, hosts its annual event tomorrow, aimed at encouraging young women to consider a career in ...